14 December 2023
Freshfields Advising AstraZeneca on $1.1bn Icosavax Acquisition
Advising firms
Deal team
19 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Sebastian Fain Lead | Freshfields | Partner | M&A | Not stated |
| Oliver Board | Freshfields | Counsel | M&A | Not stated |
| Arash Ardalan | Freshfields | Senior associate | M&A | Not stated |
| Kelsey MacElroy | Freshfields | Senior associate | M&A | Not stated |
| Connor Smith | Freshfields | Associate | M&A | Not stated |
| Vinita Kailasanath | Freshfields | Partner | life sciences | Not stated |
| Sora Park | Freshfields | Associate | life sciences | Not stated |
| Jake Silvers | Freshfields | Associate | life sciences | Not stated |
| Madeleine Tavcar | Freshfields | Associate | life sciences | Not stated |
| Nicole Foster | Freshfields | Partner | executive compensation and employee benefits | Not stated |
| Jordan Salzman | Freshfields | Counsel | executive compensation and employee benefits | Not stated |
| Lina Zhu | Freshfields | Associate | executive compensation and employee benefits | Not stated |
| Mary Lehner | Freshfields | Partner | antitrust | Not stated |
| Jenny Leahy | Freshfields | Partner | antitrust | Not stated |
| Simon Priddis | Freshfields | Partner | antitrust | Not stated |
| Laura Onken | Freshfields | Counsel | antitrust | Not stated |
| Remony Vials | Freshfields | Associate | antitrust | Not stated |
| Claude Stansbury | Freshfields | Partner | tax | Not stated |
| Hannah Golden | Freshfields | Associate | tax | Not stated |
Stated terms
- Stated value
- USD 1.10bn ($1.1bn)
- What the figure measures
- Total transaction value
- Client
- AstraZenecaBuy-side
- Counterparties
- Icosavax (Target)